nodes	percent_of_prediction	percent_of_DWPC	metapath
Mequitazine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0653	0.108	CbGpPWpGaD
Mequitazine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.051	0.0842	CbGpPWpGaD
Mequitazine—Acetophenazine—DRD2—nicotine dependence	0.0407	0.103	CrCbGaD
Mequitazine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.0405	0.0669	CbGpPWpGaD
Mequitazine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.0265	0.0437	CbGpPWpGaD
Mequitazine—Triflupromazine—DRD2—nicotine dependence	0.025	0.0632	CrCbGaD
Mequitazine—Acepromazine—DRD2—nicotine dependence	0.0231	0.0585	CrCbGaD
Mequitazine—Thioproperazine—DRD2—nicotine dependence	0.0226	0.0572	CrCbGaD
Mequitazine—Pipotiazine—DRD2—nicotine dependence	0.0222	0.0563	CrCbGaD
Mequitazine—Mesoridazine—DRD2—nicotine dependence	0.0219	0.0555	CrCbGaD
Mequitazine—HRH1—Monoamine GPCRs—DRD2—nicotine dependence	0.0216	0.0357	CbGpPWpGaD
Mequitazine—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.0212	0.0351	CbGpPWpGaD
Mequitazine—Prochlorperazine—DRD2—nicotine dependence	0.0212	0.0538	CrCbGaD
Mequitazine—Fluphenazine—DRD2—nicotine dependence	0.0192	0.0486	CrCbGaD
Mequitazine—Mianserin—DRD2—nicotine dependence	0.0192	0.0486	CrCbGaD
Mequitazine—Propiomazine—DRD2—nicotine dependence	0.0185	0.0468	CrCbGaD
Mequitazine—HRH1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0181	0.03	CbGpPWpGaD
Mequitazine—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0179	0.0295	CbGpPWpGaD
Mequitazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0168	0.0278	CbGpPWpGaD
Mequitazine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0166	0.0274	CbGpPWpGaD
Mequitazine—Thioridazine—DRD2—nicotine dependence	0.0165	0.0419	CrCbGaD
Mequitazine—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.0164	0.0271	CbGpPWpGaD
Mequitazine—Trimipramine—DRD2—nicotine dependence	0.0162	0.0409	CrCbGaD
Mequitazine—Methotrimeprazine—DRD2—nicotine dependence	0.0158	0.04	CrCbGaD
Mequitazine—Promethazine—DRD2—nicotine dependence	0.0156	0.0394	CrCbGaD
Mequitazine—Trifluoperazine—DRD2—nicotine dependence	0.0153	0.0389	CrCbGaD
Mequitazine—Perphenazine—DRD2—nicotine dependence	0.0152	0.0384	CrCbGaD
Mequitazine—Quetiapine—DRD2—nicotine dependence	0.0149	0.0377	CrCbGaD
Mequitazine—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0145	0.0239	CbGpPWpGaD
Mequitazine—Desipramine—DRD2—nicotine dependence	0.0141	0.0358	CrCbGaD
Mequitazine—Promazine—DRD2—nicotine dependence	0.0137	0.0347	CrCbGaD
Mequitazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0136	0.0225	CbGpPWpGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.0124	0.0205	CbGpPWpGaD
Mequitazine—Chlorpromazine—DRD2—nicotine dependence	0.012	0.0305	CrCbGaD
Mequitazine—Imipramine—DRD2—nicotine dependence	0.012	0.0303	CrCbGaD
Mequitazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.011	0.0182	CbGpPWpGaD
Mequitazine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0108	0.0179	CbGpPWpGaD
Mequitazine—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.0102	0.0168	CbGpPWpGaD
Mequitazine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00977	0.0161	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00892	0.0147	CbGpPWpGaD
Mequitazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00891	0.0147	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00877	0.0145	CbGpPWpGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00829	0.0137	CbGpPWpGaD
Mequitazine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00768	0.0127	CbGpPWpGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00753	0.0124	CbGpPWpGaD
Mequitazine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00724	0.012	CbGpPWpGaD
Mequitazine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00714	0.0118	CbGpPWpGaD
Mequitazine—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00611	0.0101	CbGpPWpGaD
Mequitazine—HRH1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00576	0.00952	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00567	0.00937	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00504	0.00833	CbGpPWpGaD
Mequitazine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00502	0.00829	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00496	0.00819	CbGpPWpGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00494	0.00816	CbGpPWpGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00486	0.00803	CbGpPWpGaD
Mequitazine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00473	0.00782	CbGpPWpGaD
Mequitazine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00467	0.00771	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00458	0.00756	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.0045	0.00744	CbGpPWpGaD
Mequitazine—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.00442	0.0073	CbGpPWpGaD
Mequitazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00417	0.00688	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0041	0.00677	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.00395	0.00653	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.00389	0.00643	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.00376	0.00621	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.0037	0.00611	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.00359	0.00593	CbGpPWpGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00357	0.0059	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.00353	0.00584	CbGpPWpGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00351	0.0058	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—DRD2—nicotine dependence	0.00272	0.00449	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	0.0027	0.00447	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.00267	0.00442	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.00266	0.0044	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	0.00212	0.00351	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—FGD1—nicotine dependence	0.00212	0.00351	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.00209	0.00345	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.00209	0.00345	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	0.00193	0.00319	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.0019	0.00314	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	0.00187	0.0031	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.00184	0.00305	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	0.00154	0.00254	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.00151	0.0025	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—DRD2—nicotine dependence	0.00139	0.0023	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.00137	0.00227	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—WASF2—nicotine dependence	0.00132	0.00218	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.0013	0.00215	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—WASF1—nicotine dependence	0.00127	0.00209	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.00125	0.00206	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.00124	0.00205	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—OPRM1—nicotine dependence	0.00114	0.00188	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.00112	0.00185	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—DRD2—nicotine dependence	0.000824	0.00136	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.000811	0.00134	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000809	0.00134	CbGpPWpGaD
